173 related articles for article (PubMed ID: 30776883)
1. Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea.
Kim HS; Nam CM; Jang SY; Choi SK; Han M; Kim S; Moneta MV; Lee SY; Cho JM; Novick D; Rha SY
Cancer Res Treat; 2019 Oct; 51(4):1380-1391. PubMed ID: 30776883
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Treatment Pattern of Extremity Soft Tissue Sarcoma in Korea, 2009-2011: A Nationwide Study Based on the Health Insurance Review and Assessment Service Database.
Kang S; Kim HS; Choi ES; Han I
Cancer Res Treat; 2015 Oct; 47(4):575-82. PubMed ID: 25687875
[TBL] [Abstract][Full Text] [Related]
3. Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study.
Oh CR; Hong JY; Kim JH; Lee JS; Kim HS; Kim TW; Ahn JH; Kim JE
Target Oncol; 2020 Aug; 15(4):485-493. PubMed ID: 32607656
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan.
Nakamura T; Asanuma K; Hagi T; Sudo A
Drug Des Devel Ther; 2020; 14():4215-4220. PubMed ID: 33116409
[TBL] [Abstract][Full Text] [Related]
5. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
[TBL] [Abstract][Full Text] [Related]
6. Extremity soft tissue sarcoma with multiple primary malignancies--Characteristics and outcome.
Lopez-Oliva CL; Yun JY; Kim HS; Han I
Eur J Surg Oncol; 2016 Apr; 42(4):567-73. PubMed ID: 26873637
[TBL] [Abstract][Full Text] [Related]
7. Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival.
Garbay D; Maki RG; Blay JY; Isambert N; Piperno Neumann S; Blay C; Zanardi E; Boudou-Rouquette P; Bozec L; Duffaud F; Bertucci F; Italiano A
Ann Oncol; 2013 Jul; 24(7):1924-1930. PubMed ID: 23493135
[TBL] [Abstract][Full Text] [Related]
8. Treating soft tissue sarcomas with adjuvant chemotherapy.
Patrikidou A; Domont J; Cioffi A; Le Cesne A
Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
[TBL] [Abstract][Full Text] [Related]
9. [An analysis of incidence trends and characteristics of soft tissue sarcoma in Beijing, 1999-2013].
Yang L; Fang ZW; Fan ZF; Wang N; Yuan YN; Li HC; Liu S
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):471-476. PubMed ID: 28635239
[No Abstract] [Full Text] [Related]
10. A population-based study of soft tissue sarcoma incidence and survival in Australia: An analysis of 26,970 cases.
Bessen T; Caughey GE; Shakib S; Potter JA; Reid J; Farshid G; Roder D; Neuhaus SJ
Cancer Epidemiol; 2019 Dec; 63():101590. PubMed ID: 31520939
[TBL] [Abstract][Full Text] [Related]
11. Update on systemic therapy for advanced soft-tissue sarcoma.
Smrke A; Wang Y; Simmons C
Curr Oncol; 2020 Feb; 27(Suppl 1):25-33. PubMed ID: 32174755
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First-Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials.
Younger E; Litière S; Le Cesne A; Mir O; Gelderblom H; Italiano A; Marreaud S; Jones RL; Gronchi A; van der Graaf WTA
Oncologist; 2018 Oct; 23(10):1250-1259. PubMed ID: 29650688
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
14. Incidences of Primary Soft Tissue Sarcoma Diagnosed on Extremities and Trunk Wall: A Population-Based Study in Taiwan.
Hung GY; Yen CC; Horng JL; Liu CY; Chen WM; Chen TH; Liu CL
Medicine (Baltimore); 2015 Oct; 94(41):e1696. PubMed ID: 26469906
[TBL] [Abstract][Full Text] [Related]
15. Sarcoma epidemiology and cancer-related hospitalisation in Western Australia from 1982 to 2016: a descriptive study using linked administrative data.
Wright CM; Halkett G; Carey Smith R; Moorin R
BMC Cancer; 2020 Jul; 20(1):625. PubMed ID: 32631311
[TBL] [Abstract][Full Text] [Related]
16. An updated incidence trends of soft-tissue sarcoma and cancer-specific survival of patients with primary soft-tissue sarcoma of liver: a population-based study.
Zhang Y; Wu Z; Chang J; Jiang W; Wang Y; Wang H; Li J; Li C; Li X
Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):689-698. PubMed ID: 33115276
[No Abstract] [Full Text] [Related]
17. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT
Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015
[TBL] [Abstract][Full Text] [Related]
18. Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015.
Kollár A; Rothermundt C; Klenke F; Bode B; Baumhoer D; Arndt V; Feller A;
Cancer Epidemiol; 2019 Dec; 63():101596. PubMed ID: 31520938
[TBL] [Abstract][Full Text] [Related]
19. Challenges of Using ICD-9-CM and ICD-10-CM Codes for Soft-Tissue Sarcoma in Databases for Health Services Research.
Hess LM; Zhu YE; Sugihara T; Fang Y; Collins N; Nicol S
Perspect Health Inf Manag; 2019; 16(Spring):1a. PubMed ID: 31019431
[TBL] [Abstract][Full Text] [Related]
20. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I;
Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
